FDA Panel discards Sanofi-Aventis's Acomplia
June 13th proved to be a black Friday for Sanofi-Aventis's diet pill named acomplia as the U.S. Food and Drug Administration (FDA) panel has collectively rejected French Drug maker plea for the approval to sell diet pill Acomplia in the U.S.
Read More...